Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRS3 | P32247 | 9/20 | 0.47 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.41 |
| ▸ | SCN1A | P35498 | 1/20 | 0.40 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.40 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.40 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.39 |
| ▸ | LTB4R2 | Q9NPC1 | 2/20 | 0.39 |
| ▸ | MMP2 | P08253 | 1/20 | 0.38 |
| ▸ | MMP9 | P14780 | 1/20 | 0.38 |
| ▸ | MMP12 | P39900 | 1/20 | 0.38 |
| ▸ | MMP13 | P45452 | 1/20 | 0.38 |
| ▸ | MMP14 | P50281 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9854183 | 0.83 | ACHE (0.48) | BRS3ACHESLC6A3SLC6A4SCN1A | |
| SCHEMBL3515660 | 0.83 | NR1H2 (0.52) | BRS3ACHESLC6A3SLC6A4LTB4R2 | |
| SCHEMBL8875151 | 0.83 | ACHE (0.48) | BRS3ACHESLC6A3SLC6A4SCN1A | |
| SCHEMBL4074654 | 0.82 | ALDH1A1 (0.47) | BRS3ACHESLC6A3SLC6A4LTB4R2 | |
| SCHEMBL10449002 | 0.81 | BRS3 (0.46) | BRS3LTB4R2MMP2MMP9MMP12 | |
| SCHEMBL6983827 | 0.81 | ACHE (0.46) | BRS3ACHESLC6A3SLC6A4SCN1A | |
| SCHEMBL283 | 0.80 | SLC6A3 (0.48) | BRS3ACHESLC6A3SLC6A4SCN1A | |
| SCHEMBL489306 | 0.80 | NR1H2 (0.48) | BRS3ACHESLC6A3SLC6A4SCN1A | |
| SCHEMBL502551 | 0.79 | SLC6A3 (0.42) | BRS3ACHESLC6A3SLC6A4SCN1A | |
| SCHEMBL9447390 | 0.78 | ACHE (0.46) | BRS3ACHESLC6A3SLC6A4SCN1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2083822-A2 | SUBSTITUTED IMIDAZOLES AS BOMBESIN RECEPTOR SUBTYPE-3 MODULATORS | Merck & Co., Inc. (US) | 2009-08-05 | — | — | EP | disclosed |
| WO-2008051404-A2 | SUBSTITUTED IMIDAZOLES AS BOMBESIN RECEPTOR SUBTYPE-3 MODULATORS | MERCK & CO., INC. (US) | 2008-05-02 | — | — | WO | disclosed |